MetaVia ROI - Return on Investment 2015-2024 | MTVA

MetaVia roi - return on investment from 2015 to 2024. Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

MetaVia ROI - Return on Investment 2015-2024 | MTVA

MetaVia roi - return on investment from 2015 to 2024. Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$148.2B
Vertex Pharmaceuticals (VRTX)$120.8B
Bristol Myers Squibb (BMY)$117.9B
Gilead Sciences (GILD)$115.1B
CSL (CSLLY)$87.1B
Regeneron Pharmaceuticals (REGN)$85.5B
GSK (GSK)$73B
Argenex SE (ARGX)$36.8B
Alnylam Pharmaceuticals (ALNY)$32.7B
BioNTech SE (BNTX)$27.8B
Illumina (ILMN)$23.6B
Biogen (BIIB)$22.8B
BeiGene (BGNE)$18.3B
Moderna (MRNA)$16B
Genmab (GMAB)$14.4B
Incyte (INCY)$14B
Insmed (INSM)$13B
BioMarin Pharmaceutical (BMRN)$12.7B
Bio-Techne Corp (TECH)$12.3B
Sarepta Therapeutics (SRPT)$12.1B
Exact Sciences (EXAS)$11.4B
Vaxcyte (PCVX)$11.3B
QIAGEN (QGEN)$10.5B
Exelixis (EXEL)$10.1B
Bio-Rad Laboratories (BIO.B)$9.4B
Intra-Cellular Therapies (ITCI)$8.8B
Roivant Sciences (ROIV)$8.8B
Repligen (RGEN)$8.5B
Revolution Medicines (RVMD)$8B
Ascendis Pharma (ASND)$7.9B